CIK 0001070081 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 1.7 B | 698.8 M | ||
| Net income (USD) | -438.2 M | -251.6 M | ||
| Diluted EPS (USD/shares) | 7.78 | -7.79 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 4 | 4 | 2026-10-14 |
| 2026-10-13 | 4 | 4 | 2026-10-09 |
| 2026-10-09 | 4 | 4 | 2026-10-07 |
| 2026-10-09 | 144 | 144 | |
| 2026-10-07 | 4 | 4 | 2026-10-05 |
| 2026-10-07 | 144 | 144 | |
| 2026-10-06 | 144 | 144 | |
| 2026-10-05 | 144 | 144 | |
| 2026-10-02 | 4 | 4 | 2026-09-30 |
| 2026-09-30 | 144 | 144 | |
| 2026-09-21 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-09-21 |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-11 | 4 | 4 | 2026-09-09 |
| 2026-09-09 | 144 | 144 | |
| 2026-08-28 | 4 | 4 | 2026-08-26 |
| 2026-08-28 | 8-K | 8-K items 1.01 | 2026-08-25 |
| 2026-08-25 | 144/A | 144/A | |
| 2026-08-21 | 4 | 4 | 2026-08-19 |
| 2026-08-19 | 4 | 4 | 2026-08-17 |
| 2026-08-19 | 144 | 144 | |
| 2026-08-17 | 144 | 144 | |
| 2026-08-13 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-08-12 |
| 2026-08-06 | 4 | 4 | 2026-08-04 |
| 2026-08-04 | 144 | 144 | |
| 2026-07-30 | 4 | 4 | 2026-07-28 |
Forms on file (last 1,000): 4 435, 144 204, 8-K 133, SC 13G/A 52, 10-Q 28, SC 13G 18, 3 14, SCHEDULE 13G/A 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PTCT (0.002 USD), /gw/filings/filings?ticker=PTCT&form=8-K, /gw/filings/facts?ticker=PTCT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange